The type of K-ras mutation determines prognosis in colerectal cancer

American Journal of Surgery

Volumn 175, Issue 3, 1998, Pages 198-202

  Cerottini, Jean Philippe ^a   Caplin, Scott ^a   Saraga, Emilia ^a   Givel, Jean Claude ^a   Benhattar, Jean ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; COLORECTAL CANCER; CYTOGENETICS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENES, RAS; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0032032984     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(97)00283-3     Document Type: Article

References (33)

1. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor developement. NEJM. 319:1988;525-532.
2. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
3. Barbacid M. Ras genes. Ann Rev Biochem. 56:1987;779-827.
4. Losi L, Benhattar J, Costa J. Stability of K-ras mutations throughout the natural history of human colorectal cancer. Eur J Cancer. 28A:1992;1115-1120.
5. Suchy B, Zietz C, Rabes HM. K-ras point mutations in human colorectal carcinomas relation to aneuploidy and metastasis . Int J Cancer. 52:1992;30-33.
6. Dix BR, Robbins P, Soong R, et al. The common molecular genetic alterations in Dukes' B and C colorectal carcinomas are not short-term prognostic indicators of survival. Int J Cancer. 59:1994;747-751.
7. Bos JL. The ras gene family and human carcinogenesis. Mutat Res. 195:1988;255-271.
8. Bos JL. Ras oncogenes in human cancer a review . Cancer Res. 49:1989;4682-4689.
9. Bos JL, Fearon ER, Hamilton SR, et al. Prevalence of K-ras mutations in human colorectal cancer. Nature. 327:1987;293-297.
10. Forrester K, Almoguera C, Han K, et al. Detection of high incidence of K-ras oncogenes during human carcinogenesis. Nature. 327:1989;298-303.
11. Burmer GC, Loeb LA. Mutations in the K-ras-2 oncogene during progressive stages of human colon carcinoma. Proc Natl Acad Sci USA. 86:1989;2403-2407.
12. Shaw P, Tardy S, Benito E, et al. Occurrence of Ki-ras and p53 mutations in primary colorectal tumors. Oncogene. 6:1991;2121-2128.
13. Laurent-Puig P, Olschwang S, Delattre O, et al. Association of Ki-ras mutation with differentiation and tumor-formation pathways in colorectal carcinoma. Int J Cancer. 49:1991;220-223.
14. Finkelstein SD, Sayegh R, Christensen S, et al. Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type. Cancer. 71:1993;3827-3838.
15. Dukes CE. The classification of cancer of the rectum. J Pathol Bacteriol. 35:1932;323-332.
16. Benhattar J, Losi L, Chaubert P, et al. Prognostic significance of K-ras mutations in colorectal carcinoma. Gastroenterology. 104:1993;1044-1048.
17. Field JK, Spandikos DA. The role of ras and myc oncogenes in human solid tumors and their relevance in diagnosis and prognosis. Anticancer Res. 10:1990;1-22.
18. Michelassi F, Grad G, Erroi F, et al. Relationship between ras oncogene expression and pathological features of colonic carcinoma. Hepatogastroenterology. 37:1990;513-516.
19. Miyahara M, Saito T, Kaketani K, et al. Clinical significance of ras p21 overexpression for patients with an advanced colorectal cancer. Dis Colon Rectum. 34:1991;1097-1102.
20. Laurent-Puig P, Olschwang S, Delattre O, et al. Survival and acquired genetic alterations in colorectal cancer. Gastroenterology. 102:1992;1136-1141.
21. Blin N, Stafford DM. A general method for isolation of high molecular weight DNA from eukaryotes. Nucl Ac Res. 3:1976;2303-2308.
22. Chaubert P, Bautista D, Benhattar J. An improved method for rapid screening of DNA mutations by non-radioactive single-strand conformation polymorphism procedure. Biotechniques. 15:1993;586.
23. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
24. Peto R, Pike MC. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer. 35:1977;1-39.
25. Bell SM, Scott N, Cross D, et al. Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology. 104:1993;57-64.
26. Sun XF, Hatschek T, Wingren S, et al. Ras p21 expression in relation to histopathological variables and prognosis in colorectal adenocarcinoma. Acta Oncol. 30:1991;933-939.
27. Halter SA, Webb L, Rose J. Lack of ras mutations and prediction of long-term survival in carcinoma of the colon. Mod Pathol. 5:1992;131-134.
28. Morrin M, Kelly M, Barrett N, et al. Mutations of Ki-ras and p53 genes in colorectal cancer and their prognostic significance. Gut. 35:1994;1627-1631.
29. Tanaka M, Omura K, Watanabe Y, et al. Prognostic factors of colorectal cancer K-ras mutation, overexpression of the p53 protein, and cell proliferative activity . J Surg Oncol. 57:1994;57-64.
30. Pricolo VE, Finkelstein SD, Tsung-Teh W, et al. Prognostic value of TP53 and K-ras-2 mutational analysis in stage III carcinoma of the colon. Am J Surg. 171:1996;41-45.
31. Jen J, Kim H, Piantadosi S, et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. NEJM. 331:1994;213-221.
32. Finkelstein SD, Sayegh R, Bakker A, et al. Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis. Arch Surg. 128:1993;526-531.
33. Moerkerk P, Arends JW, van Driel M, et al. Type and number of Ki-ras point mutations relate to stage of human colorectal cancer. Cancer Res. 54:1994;3376-3378.